Literature DB >> 2065888

Murine acquired immunodeficiency syndrome (MAIDS): an animal model to study the AIDS pathogenesis.

P Jolicoeur1.   

Abstract

Murine AIDS (MAIDS) is a disease that shows many similarities with human AIDS. Several immunological parameters of the disease have been analyzed and genetic studies have mapped a gene (or genes) of resistance in the H-2 complex and shown that the genetic background of the mouse can significantly modify some features of the disease. The etiologic agent of MAIDS is a defective murine leukemia virus that seems able to induce disease in the absence of virus replication. This defective virus induces proliferation of its target cells and the cell expansion was found to be oligoclonal, thus suggesting that the immunodeficiency observed in these mice is a paraneoplastic syndrome. The excellent response of MAIDS mice to antineoplastic agents is consistent with this notion. This animal model has already been useful in stimulating the emergence of novel questions and the formulation of new hypotheses about human AIDS, namely about the role of defective HIV, the role of HIV replication in the progression of the disease, and the importance to identify the target cells of HIV in vivo. Although MAIDS and AIDS are not identical and are induced by retroviruses of different classes, the availability of such a model in an easily accessible small animal species, whose genetics is very sophisticated, may be instrumental in understanding the pathogenesis of AIDS if some of the cellular and molecular affected pathways are common in both diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2065888     DOI: 10.1096/fasebj.5.10.2065888

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  58 in total

1.  Development of a real-time PCR assay using SYBR Green I for provirus load quantification in a murine model of AIDS.

Authors:  Anna Casabianca; Chiara Orlandi; Alessandra Fraternale; Mauro Magnani
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Activity of a novel combined antiretroviral therapy of gemcitabine and decitabine in a mouse model for HIV-1.

Authors:  Christine L Clouser; Colleen M Holtz; Mary Mullett; Daune L Crankshaw; Jacquie E Briggs; M Gerard O'Sullivan; Steven E Patterson; Louis M Mansky
Journal:  Antimicrob Agents Chemother       Date:  2012-01-23       Impact factor: 5.191

3.  Murine AIDS requires CD154/CD40L expression by the CD4 T cells that mediate retrovirus-induced disease: Is CD4 T cell receptor ligation needed?

Authors:  Wen Li; William R Green
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

4.  Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.

Authors:  N A Giese; R T Gazzinelli; J K Actor; R A Morawetz; M Sarzotti; H C Morse
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

5.  Induction of intestinal lesions in nu/nu mice induced by transfer of lymphocytes from syngeneic mice infected with murine retrovirus.

Authors:  K Suzuki; T Narita; R Yui; K Ohtsuka; S Inada; T Kimura; Y Okada; M Makino; T Mizuochi; H Asakura; M Fujiwara
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

6.  Divergent and dynamic activity of endogenous retroviruses in burn patients and their inflammatory potential.

Authors:  Kang-Hoon Lee; HyungChul Rah; Tajia Green; Young-Kwan Lee; Debora Lim; Jean Nemzek; Wendy Wahl; David Greenhalgh; Kiho Cho
Journal:  Exp Mol Pathol       Date:  2014-02-06       Impact factor: 3.362

7.  Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs.

Authors:  C Simard; M Huang; P Jolicoeur
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus.

Authors:  J M Pozsgay; M W Beilharz; B D Wines; A D Hess; P M Pitha
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages.

Authors:  W K Kim; Y Tang; J J Kenny; D L Longo; H C Morse
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Prognostic value of phenotypic alterations in blood lymphocyte subsets in a murine retrovirus-induced immunodeficiency syndrome (MAIDS).

Authors:  F Chau; M Levacher-Clergeot; B Desforges; L Ricatte; M Sinet
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.